Cookson Peirce & Co’s Impax Laboratories, Inc. IPXL Stock Holding History

Cookson Peirce & Co’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-54,390	Closed	-$1.92M	–	165
2015 Q3	$1.92M	Buy	54,390 +12,520	+30%	+$564K	0.32%	68
2015 Q2	$1.92M	Buy	41,870 +6,450	+18%	+$306K	0.32%	59
2015 Q1	$1.66M	Buy	+35,420	New	+$1.41M	0.29%	60

Other funds holding IPXL

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cookson Peirce & Co's IPXL Position: Q4 2015 in Review

Cookson Peirce & Co sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 54,390 shares — an estimated $1.92M sold.

Cookson Peirce & Co first reported a position in IPXL in Q1 2015 and held it in 3 quarters. The position peaked at $1.92M in Q2 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

Cookson Peirce & Co reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
Cookson Peirce & Co sold 54,390 Impax Laboratories, Inc. shares in Q4 2015, an estimated $1.92M.
Cookson Peirce & Co first reported a position in Impax Laboratories, Inc. in Q1 2015 and held it in 3 quarters.
Cookson Peirce & Co's Impax Laboratories, Inc. position peaked at $1.92M in Q2 2015.
196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on Cookson Peirce & Co's 13F filing for Q4 2015, filed 27 Jan 2016.